Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Oof

<< Previous

Bullboard Posts

Next >>

Comment by Rarbar99on Oct 14, 2021 1:10pm

200 Views

Post# 34005842

RE:RE:Oof

Speaking of stupid, do you remember a month ago when I told you that this issue is more serious than it sounds? You scoffed and tried to explain that elevated levels mean nothing because other drugs like Tylenol experience the same. I tried to explain to you that Tylenol wouldn't be approved in this day & age but unfortunately you're a bit slow.

As I said, this issue was much more serious than some of you bulls led on. I am not surprised they're completely rebranding the drug and starting over again.

personally I sold all of my shares with a small profit (avg price $1.07), and you would have to be an utter fool to hold on.

You have been wrong on literally everything you've ever said. You said $4 is a good entry price back in June.

Anyways, my time here is done. Good luck. This was a failed investment.